Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Seidel, Aprille ^a,b   Ye, Ying ^a,b   de Armas, Lesley R ^a,b   Soto, Maira ^a,b   Yarosh, William ^a,b   Marcsisin, Renee A ^a,b   Tran, Dat ^a,b,c   Selsted, Michael E ^a,b,c   Camerini, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETA DEFENSIN; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; CYCLOPEPTIDE; DEFB1 PROTEIN, HUMAN; DEFENSIN; DEFENSIN 1; DEFT1P PROTEIN, HUMAN; LUCIFERASE;

ANIMAL; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MONONUCLEAR CELL; NEUTROPHIL; PHYSIOLOGY; VIRUS REPLICATION;

ALPHA-DEFENSINS; ANIMALS; ANTI-HIV AGENTS; BETA-DEFENSINS; CELL SURVIVAL; DEFENSINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LUCIFERASES; NEUTROPHILS; PEPTIDES, CYCLIC; RECEPTORS, CXCR4; VIRUS REPLICATION;

EID: 77955439037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009737     Document Type: Article

References (49)

1. Cunliffe RN (2003) Alpha-defensins in the gastrointestinal tract. Mol Immunol 40: 463-467.
2. Nguyen TX, Cole AM, Lehrer RI (2003) Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides 24: 1647-1654.
3. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557.
4. Ayabe T, Ashida T, Kohgo Y, Kono T (2004) The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol 12: 394-398.
5. Tanabe H, Yuan J, Zaragoza MM, Dandekar S, Henschen-Edman A, et al. (2004) Paneth cell alpha-defensins from rhesus macaque small intestine. Infect Immun 72: 1470-1478.
6. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, et al. (2002) Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 99: 2129-2133.
7. Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, et al. (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286: 498-502.
8. Tran D, Tran PA, Tang YQ, Yuan J, Cole T, et al. (2002) Homodimeric thetadefensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem 277: 3079-3084.
9. Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, et al. (2002) Retrocyclin: a primate peptide that protects cells from infection by T-and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A 99: 1813-1818.
10. Wang W, Cole AM, Hong T, Waring AJ, Lehrer RI (2003) Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol 170: 4708-4716.
11. Zhang L, Yu W, He T, Yu J, Caffrey RE, et al. (2002) Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298: 995-1000.
12. Chang TL, Francois F, Mosoian A, Klotman ME (2003) CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol 77: 6777-6784.
13. Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, et al. (2003) Alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. Aids 17: F23-32.
14. Zaharatos GJ, He T, Lopez P, Yu W, Yu J, et al. (2004) alpha-defensins released into stimulated CD8+ T-cell supernatants are likely derived from residual granulocytes within the irradiated allogeneic peripheral blood mononuclear cells used as feeders. J Acquir Immune Defic Syndr 36: 993-1005.
15. Zhang L, Lopez P, He T, Yu W, Ho DD (2004) Retraction of an interpretation. Science 303: 467.
16. Chang TL, Vargas J, Jr., DelPortillo A, Klotman ME (2005) Dual role of alphadefensin-1 in anti-HIV-1 innate immunity. J Clin Invest 115: 765-773.
17. Trabattoni D, Caputo SL, Maffeis G, Vichi F, Biasin M, et al. (2004) Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr 35: 455-463.
18. Furci L, Sironi F, Tolazzi M, Vassena L, Lusso P (2007) Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 109: 2928-2935.
19. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, et al. (2003) Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 17: F39-48.
20. Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, et al. (2005) Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 79: 14318-14329.
21. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, et al. (2004) A singlenucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children. AIDS 18: 1598-1600.
22. Alp S, Skrygan M, Schlottmann R, Kreuter A, Otte JM, et al. (2005) Expression of beta-defensin 1 and 2 in nasal epithelial cells and alveolar macrophages from HIV-infected patients. Eur J Med Res 10: 1-6.
23. Feng Z, Dubyak GR, Lederman MM, Weinberg A (2006) Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 177: 782-786.
24. Jotwani R, Muthukuru M, Cutler CW (2004) Increase in HIV receptors/coreceptors/ alpha-defensins in inflamed human gingiva. J Dent Res 83: 371-377.
25. Armogida SA, Yannaras NM, Melton AL, Srivastava MD (2004) Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc 25: 297-304.
26. Jia HP, Starner T, Ackermann M, Kirby P, Tack BF, et al. (2001) Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J Pediatr 138: 109-112.
27. Kuhn L, Trabattoni D, Kankasa C, Semrau K, Kasonde P, et al. (2005) Alphadefensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr 39: 138-142.
28. Tunzi CR, Harper PA, Bar-Oz B, Valore EV, Semple JL, et al. (2000) Betadefensin expression in human mammary gland epithelia. Pediatr Res 48: 30-35.
29. Leikina E, Delanoe-Ayari H, Melikov K, Cho MS, Chen A, et al. (2005) Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 6: 995-1001.
30. Cole AL, Yang OO, Warren AD, Waring AJ, Lehrer RI, et al. (2006) HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol 176: 6900-6905.
31. Gallo SA, Wang W, Rawat SS, Jung G, Waring AJ, et al. (2006) Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem 281: 18787-18792.
32. Munk C, Wei G, Yang OO, Waring AJ, Wang W, et al. (2003) The thetadefensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 19: 875-881.
33. Owen SM, Rudolph D, Wang W, Cole AM, Sherman MA, et al. (2004) A thetadefensin composed exclusively of D-amino acids is active against HIV-1. J Pept Res 63: 469-476.
34. Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, et al. (2004) RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses 20: 1157-1165.
35. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, et al. (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78: 5147-5156.
36. Yang C, Boone L, Nguyen TX, Rudolph D, Limpakarnjanarat K, et al. (2005) theta-Defensin pseudogenes in HIV-1-exposed, persistently seronegative female sex-workers from Thailand. Infect Genet Evol 5: 11-15.
37. Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, et al. (2004) Activity of alpha-and theta-defensins against primary isolates of HIV-1. J Immunol 173: 515-520.
38. Cavrois M, De Noronha C, Greene WC (2002) A sensitive and specific enzymebased assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20: 1151-1154.
39. Lu Z, Kim KA, Suico MA, Shuto T, Li JD, et al. (2004) MEF up-regulates human beta-defensin 2 expression in epithelial cells. FEBS Lett 561: 117-121.
40. Niyonsaba F, Ogawa H, Nagaoka I (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111: 273-281.
41. Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, et al. (2001) Discovery of new human beta-defensins using a genomics-based approach. Gene 263: 211-218.
42. Shiomi K, Nakazato M, Ihi T, Kangawa K, Matsuo H, et al. (1993) Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun 195: 1336-1344.
43. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, et al. (2002) High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22: 2103-2107.
44. Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, et al. (2005) Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett 579: 162-166.
45. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76: 1427-1435.
46. Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI (1985) Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 260: 4579-4584.
47. Camerini D, Su H-P, Gamez-Torre G, Johnson ML, Zack JA, et al. (2000) Human Immunodeficiency Virus Type 1 Pathogenesis in SCID-hu Mice Correlates with Syncytium-Inducing Phenotype and Viral Replication. J Virol 74: 3196-3204.
48. O'Doherty U, Swiggard WJ, Malim MH (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74: 10074-10080.
49. Wehrly K, Chesebro B (1997) p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12: 288-293.